Febrile neutropenia, one of the most serious adverse reactions of cytostatic therapy, is a potentially fatal complication and is considered an oncological emergency. In this book, the principles, aspects in relation to infection and use of haematopoietic growth factors are dealt with in detail. The aim is to provide the practising physician with a rapid insight into current procedures for management in neutropenic patients.
